<DOC>
	<DOCNO>NCT00813995</DOCNO>
	<brief_summary>A study ass safety efficacy addition sitagliptin compare placebo patient Type 2 Diabetes Mellitus inadequate glycemic control metformin .</brief_summary>
	<brief_title>A Study Test Safety Efficacy Adding Sitagliptin Patients With Type 2 Diabetes Mellitus ( MK0431-074 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>18 78 year age Currently metformin monotherapy History Type 1 diabetes mellitus ketoacidosis Currently weight loss program maintenance phase start weight loss medication within last 8 week Has undergone surgery require general anesthesia within past 4 week plan major surgery Currently participate study participate study without investigational compound device within past 12 week History active liver disease chronic active hepatitis B C , cirrhosis symptomatic gallbladder disease HIV positive Pregnant , breastfeed plan become pregnant study User recreational illicit drug recent history ( within past year ) drug alcohol abuse dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>